Cargando…
Systemic and mucosal immune responses following oral adenoviral delivery of influenza vaccine to the human intestine by radio controlled capsule
There are several benefits of oral immunization including the ability to elicit mucosal immune responses that may protect against pathogens that invade through a mucosal surface. Our understanding of human immune biology is hampered by the difficulty in isolating mucosal cells from humans, and the f...
Autores principales: | Kim, Leesun, Martinez, C. Josefina, Hodgson, Katie A., Trager, George R., Brandl, Jennifer R., Sandefer, Erik P., Doll, Walter J., Liebowitz, Dave, Tucker, Sean N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121599/ https://www.ncbi.nlm.nih.gov/pubmed/27881837 http://dx.doi.org/10.1038/srep37295 |
Ejemplares similares
-
1947. Influenza Vaccination via Oral Tablet is Protective and Induces a Unique Mucosal Immune Response
por: Kolhatkar, Nikita, et al.
Publicado: (2018) -
Small intestinal mucosal abnormalities using video capsule endoscopy in intestinal lymphangiectasia
por: Lin, Lin, et al.
Publicado: (2023) -
An adenoviral vector-based mucosal vaccine is effective in protection against botulism
por: Xu, Q, et al.
Publicado: (2009) -
Increased mucosal CD4+ T-cell activation following vaccination with an adenoviral vector in rhesus macaques
por: Bukh, I, et al.
Publicado: (2012) -
Adenoviral-vectored next-generation respiratory mucosal
vaccines against COVID-19
por: Afkhami, Sam, et al.
Publicado: (2023)